Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1991 1
1992 2
1993 2
1994 5
1995 4
1996 1
1997 1
1998 2
1999 1
2000 1
2001 1
2010 1
2011 1
2012 2
2013 4
2014 2
2015 2
2017 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection.
Persu A, Lopez-Sublet M, Al-Hussaini A, Pappaccogli M, Radhouani I, Van der Niepen P, Adair W, Beauloye C, Brillet PY, Chan N, Chenu P, Devos H, Escaned J, Garcia-Guimaraes M, Hammer F, Jackson R, Jebri S, Kotecha D, Macaya F, Mahon C, Natarajan N, Neghal K, Nicol ED, Parke KS, Premawardhana D, Sajitha A, Wormleighton J, Samani NJ, McCann GP, Adlam D. Persu A, et al. Among authors: chenu p. JAMA Cardiol. 2022 Feb 1;7(2):159-166. doi: 10.1001/jamacardio.2021.4690. JAMA Cardiol. 2022. PMID: 34817541 Free PMC article.
Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys.
Vynckier P, De Sutter J, De Pauw M, Vandekerckhove H, De Backer G, Vervaet P, Deweerdt N, Dendale P, Persu A, Janssen A, Chenu P, Kotseva K, Gevaert S, De Bacquer D, De Smedt D; EUROASPIRE V Investigators Group; EUROASPIRE IV. Vynckier P, et al. Among authors: chenu p. Acta Cardiol. 2023 Jul;78(5):607-613. doi: 10.1080/00015385.2023.2169439. Epub 2023 Feb 13. Acta Cardiol. 2023. PMID: 36779380
The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients.
Pappaccogli M, Di Monaco S, Warchoł-Celińska E, Lorthioir A, Amar L, Aparicio LS, Beauloye C, Bruno RM, Chenu P, de Leeuw P, De Backer T, Delmotte P, Dika Z, Gordin D, Heuten H, Iwashima Y, Krzesinski JM, Kroon AA, Mazzolai L, Poch E, Sarafidis P, Seinturier C, Spiering W, Toubiana L, Van der Niepen P, van Twist D, Visonà A, Wautrecht JC, Witowicz H, Xu J, Prejbisz A, Januszewicz A, Azizi M, Persu A; European/International FMD Registry and Initiative (FEIRI), and the Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH). Pappaccogli M, et al. Among authors: chenu p. Cardiovasc Res. 2021 Feb 22;117(3):950-959. doi: 10.1093/cvr/cvaa102. Cardiovasc Res. 2021. PMID: 32282921 Free article.
The STIB score: a simple clinical test to predict clopidogrel resistance.
Legrand D, Barbato E, Chenu P, Magne J, Vrolix M, Wijns W, Legrand V; STIB investigators. Legrand D, et al. Among authors: chenu p. Acta Cardiol. 2015 Oct;70(5):516-21. doi: 10.2143/AC.70.5.3110511. Acta Cardiol. 2015. PMID: 26567810 Free article. Clinical Trial.
Reduction of Lipid-Core Burden Index in Nonculprit Lesions at Follow-Up after ST-Elevation Myocardial Infarction: A Randomized Study of Bioresorbable Vascular Scaffold versus Optimal Medical Therapy.
Kefer J, Chenu P, Gurné O, Maes F, Tamakloé T, Beauloye C. Kefer J, et al. Among authors: chenu p. J Interv Cardiol. 2021 Jul 1;2021:5590093. doi: 10.1155/2021/5590093. eCollection 2021. J Interv Cardiol. 2021. PMID: 34290573 Free PMC article. Clinical Trial.
Intestinal disaccharidase activity in giardiasis.
Chenu P, Gottrand F, Turck D, Dutoit E. Chenu P, et al. J Pediatr Gastroenterol Nutr. 1992 Apr;14(3):356-7. doi: 10.1097/00005176-199204000-00025. J Pediatr Gastroenterol Nutr. 1992. PMID: 1619546 No abstract available.
Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial.
Barbato E, Herman A, Benit E, Janssens L, Lalmand J, Hoffer E, Chenu P, Guédès A, Missault L, Pirenne B, Cardinal F, Vercauteren S, Wijns W. Barbato E, et al. Among authors: chenu p. J Cardiovasc Transl Res. 2014 Mar;7(2):226-31. doi: 10.1007/s12265-013-9513-9. Epub 2013 Oct 19. J Cardiovasc Transl Res. 2014. PMID: 24142804 Clinical Trial.
Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial.
Barbato E, Herman A, Benit E, Janssens L, Lalmand J, Hoffer E, Chenu P, Guédès A, Missault L, Pirenne B, Cardinal F, Vercauteren S, Wijns W. Barbato E, et al. Among authors: chenu p. Atherosclerosis. 2015 Jun;240(2):351-4. doi: 10.1016/j.atherosclerosis.2015.03.045. Epub 2015 Apr 7. Atherosclerosis. 2015. PMID: 25875387 Clinical Trial.
39 results